Atea Pharmaceuticals, Inc. — All Filings
294 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DFAN14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POSASR
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000786 | Mar 26, 2026 | — |
| 4 | 4 | 0001193125-26-106547 | Mar 13, 2026 | Mar 11, 2026 |
| 10-K | 10-K | 0001193125-26-094159 | Mar 5, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-093961 | Mar 5, 2026 | — |
| SCHEDULE 13G | — | 0001373604-26-000010 | Feb 9, 2026 | — |
| 4 | 4 | 0001193125-26-036281 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | 4 | 0001193125-26-036272 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | 4 | 0001193125-26-036270 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | 4 | 0001193125-26-036269 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | 4 | 0001193125-26-036268 | Feb 3, 2026 | Jan 31, 2026 |
| 4 | 4 | 0001193125-26-036261 | Feb 3, 2026 | Jan 31, 2026 |
| 8-K | 8-K | 0001193125-26-007081 | Jan 8, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-25-002957 | Dec 5, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-277815 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-277627 | Nov 12, 2025 | — |
| S-8 | S-8 | 0001193125-25-175553 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-105123 | Aug 7, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0001193125-25-175433 | Aug 7, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-001974 | Aug 6, 2025 | — |
| 4 | 4 | 0000950170-25-089607 | Jun 24, 2025 | Jun 20, 2025 |
| 4 | 4 | 0000950170-25-089609 | Jun 24, 2025 | Jun 20, 2025 |
| 4 | 4 | 0000950170-25-089606 | Jun 24, 2025 | Jun 20, 2025 |
| 4 | 4 | 0000950170-25-089605 | Jun 24, 2025 | Jun 20, 2025 |
| 4 | 4 | 0000950170-25-089608 | Jun 24, 2025 | Jun 20, 2025 |
| 4 | 4 | 0000950170-25-089604 | Jun 24, 2025 | Jun 20, 2025 |
| 4 | 4 | 0000950170-25-089603 | Jun 24, 2025 | Jun 20, 2025 |
| 3 | 3 | 0000950170-25-089596 | Jun 24, 2025 | Jun 20, 2025 |
| 8-K | 8-K | 0001193125-25-143750 | Jun 20, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-071707 | May 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-069367 | May 12, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001193125-25-117809 | May 12, 2025 | — |
| DEF 14A | DEF 14A | 0001193125-25-104019 | Apr 29, 2025 | Jun 20, 2025 |
| SCHEDULE 13G/A | — | 0002052113-25-001472 | Apr 23, 2025 | — |
| SCHEDULE 13D/A | — | 0000921895-25-001112 | Apr 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-083523 | Apr 17, 2025 | Apr 16, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-072426 | Apr 3, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-25-069935 | Apr 1, 2025 | — |
| 8-K | 8-K | 0001193125-25-069932 | Apr 1, 2025 | Mar 31, 2025 |
| DEFA14A | DEFA14A | 0001193125-25-064180 | Mar 26, 2025 | — |
| DFAN14A | — | 0000921895-25-000883 | Mar 26, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-25-060808 | Mar 24, 2025 | — |
| 8-K | 8-K | 0001193125-25-060794 | Mar 24, 2025 | Mar 21, 2025 |
| SCHEDULE 13D/A | — | 0000921895-25-000843 | Mar 21, 2025 | — |
| 10-K | 10-K | 0000950170-25-034808 | Mar 6, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001193125-25-048426 | Mar 6, 2025 | — |
| SCHEDULE 13D | — | 0000921895-25-000684 | Mar 4, 2025 | — |
| 4 | 4 | 0000950170-25-025901 | Feb 24, 2025 | Feb 20, 2025 |
| 3 | 3 | 0000950170-25-025892 | Feb 24, 2025 | Feb 20, 2025 |
| 8-K | 8-K | 0001193125-25-032826 | Feb 24, 2025 | Feb 20, 2025 |
| SCHEDULE 13G/A | — | 0000935836-25-000162 | Feb 14, 2025 | — |